Meadow Creek Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $454K | Hold |
5,644
| – | – | 0.01% | 749 |
|
|
2019
Q2 | $410K | Sell |
5,644
-1,020
| -15% | -$74.1K | 0.01% | 787 |
|
|
2019
Q1 | $623K | Sell |
6,664
-68
| -1% | -$6.36K | 0.01% | 608 |
|
|
2018
Q4 | $491K | Sell |
6,732
-64,770
| -91% | -$4.72M | 0.01% | 628 |
|
|
2018
Q3 | $6.26M | Sell |
71,502
-7,174
| -9% | -$628K | 0.12% | 165 |
|
|
2018
Q2 | $7.75M | Buy |
78,676
+18,802
| +31% | +$1.85M | 0.16% | 128 |
|
|
2018
Q1 | $7.13M | Buy |
+59,874
| New | +$7.13M | 0.15% | 137 |
|